270870.KQ Newtree Co.Ltd
- Market cap
- KRW 32.6B
- P/E
- 6.8x
- P/B
- 0.30x
- ROE
- 14.7%
- Dividend yield
- 12.26%
- Fundamental score
- 1.6/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 270870.KQ undervalued?
Graham numberThe Graham number of Newtree Co.Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Newtree Co.Ltd fundamental analysis
9 of 22 checks passedROE 1/2
Moderate return on equity (14.7%), between 10% and 20%.
ROA 1/1
Return on assets (11.0%) is above the industry median (1.4%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-150.2%) is below the industry median (1.8%).
Revenue Growth 0/2
Revenue shrank 20.2% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Debt is not reported.
Interest Coverage 1/1
EBIT is 51.5x against interest expense, well covered.
PE vs Market 1/1
PE (6.8x) is below the market median (11.3x).
PE vs Industry 1/1
PE (6.8x) is below the industry median (11.4x).
PBV 1/1
Price to book (0.3x) is below the industry median (0.9x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 2.0, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Newtree Co.Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Newtree Co.Ltd
Newtree Co., Ltd. provides health and beauty products in South Korea, China, and the United States. It also offers raw materials, such as fingerroot extract powder, low molecular collagen peptide, licorice extract, ceylon moss, and aster spathulifolius. The company was incorporated in 2001 and is headquartered in Seoul, South Korea.
Full company profileNewtree Co.Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Newtree Co.Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 33.1B | 60.4B | 87.2B | 125B | 190B | 247B | 199B | 151B | 122B | 101B | 108B |
| Gross Profit | 23.5B | 44.3B | 65.7B | 96.6B | 149B | 192B | 152B | 119B | 94.1B | 72.0B | 78.2B |
| Operating Income | 1.22B | 4.14B | 9.30B | 12.0B | 23.5B | 21.1B | 4.54B | 8.84B | 4.93B | -2.27B | -38.3M |
| EBITDA | - | - | - | - | - | - | 9.83B | 8.09B | 6.61B | 1.27B | 21.6B |
| Net Income | 307M | 2.09B | 2.18B | 9.54B | 19.2B | 19.7B | 4.74B | 4.61B | 4.81B | -2.42B | 15.9B |
| EPS | 51 | 349 | 241 | 1,053 | 2,189 | 2,211 | 527 | 512 | 534 | -269 | 1,770 |
| Balance Sheet | |||||||||||
| Total Assets | 12.4B | 23.9B | 58.9B | 77.5B | 102B | 148B | 147B | 133B | 139B | 137B | 145B |
| Total Liabilities | 7.56B | 17.0B | 9.96B | 20.1B | 31.7B | 54.9B | 49.4B | 31.4B | 32.4B | 31.6B | 35.3B |
| Shareholders' Equity | 4.84B | 6.92B | 49.0B | 57.4B | 70.5B | 93.3B | 97.3B | 99.8B | 106B | 104B | 108B |
| Cash & Short-term Investments | 4.08B | 9.46B | 36.6B | 41.6B | 25.3B | 64.9B | 52.1B | 34.1B | 38.5B | 18.4B | 8.57B |
| Total Debt | 4.18B | 7.43B | 33.6M | 943M | 11.0B | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -28.8M | 4.09B | 7.90B | 7.49B | 4.35B | 13.0B | -3.63B | 8.17B | 5.03B | 11.2B | -6.79B |
| Capital Expenditure | 564M | 893M | 1.39B | 3.04B | 18.0B | 2.95B | 7.46B | 309M | 554M | 614M | 764M |
| Free Cash Flow | - | - | - | 10.7B | -15.3B | 9.65B | -11.2B | 7.86B | 4.48B | 10.5B | -7.55B |
| Ratios | |||||||||||
| ROE | 6.3% | 30.2% | 4.4% | 16.6% | 27.2% | 21.1% | 4.9% | 4.6% | 4.5% | -2.3% | 14.7% |
| ROA | 2.5% | 8.8% | 3.7% | 12.3% | 18.8% | 13.3% | 3.2% | 3.5% | 3.5% | -1.8% | 11.0% |
| Net Profit Margin | 0.9% | 3.5% | 2.5% | 7.6% | 10.1% | 8.0% | 2.4% | 3.0% | 3.9% | -2.4% | 14.7% |
| Debt to Equity | 0.86x | 1.07x | 0.00x | 0.02x | 0.16x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Newtree Co.Ltd dividends
- Dividend yield
- 12.26%
- Forward dividend
- 450.00 KRW
- Payout ratio
- -
- Ex-dividend date
- Apr 17, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | KRW 2.25B | 250 | 48.8% |
| 2022 | KRW 2.23B | 248 | 46.9% |
| 2021 | KRW 2.19B | 246 | 11.1% |
| 2020 | KRW 1.36B | 155 | 7.1% |
| 2019 | KRW 904M | 100 | 9.5% |
| 2018 | KRW 481M | 53 | 22.1% |
| 2017 | KRW 481M | 80 | 23.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Newtree Co.Ltd
- Insiders 56.83%
- Institutions 0.00%
- Public & others 43.18%
- Shares outstanding 8.87M
- Free float 3.55M
Newtree Co.Ltd company profile
- Company name
- Newtree Co.Ltd
- Ticker
- 270870.KQ
- ISIN
- KR7270870009
- Exchange
- KOSDAQ
- Sector
- Consumer Defensive
- Industry
- Oil, Gas & Consumable Fuels
- Employees
- 90
- Fiscal year end
- December
- Address
- NEWTREE Laboratory, Seoul, South Korea
- Phone
- 82 2 565 3494
- Website
- inewtree.com
About Newtree Co.Ltd
Newtree Co., Ltd. provides health and beauty products in South Korea, China, and the United States. It also offers raw materials, such as fingerroot extract powder, low molecular collagen peptide, licorice extract, ceylon moss, and aster spathulifolius. The company was incorporated in 2001 and is headquartered in Seoul, South Korea.